跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Versant-XR - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Versant-XR
Approved
STANDARD
Versant-XR
Amherst Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1c2e896970ada069
Company
Amherst Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
1c2e896970ada069
Drug Approval Philippines Name
Versant-XR
Product Name
Versant-XR
Registration Number
DRP-1775
Brand Name
Versant-XR
Generic Name
Felodipine
Dosage Form
Extended-Release Tablet
Dosage Strength
10 mg
Manufacturer
Amherst Laboratories, Inc.
Trader
UNILAB, Inc.
Issuance Date
29 June 2024
Expiry Date
10 December 2029
Pharmacologic Category
Calcium Channel Blocker
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1c2e896970ada069
Type
Standard
Back to Philippines FDA Approvals